Emerging evidence indicates that HIF-1α may enhance TGF-β1/Smad pathway activity through non-canonical routes (e.g., PI3K/Akt) (15), yet the role of this mechanism in pancreatic cancer ECM regulation remains uncharacterized. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.